Navigation Links
Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants
Date:6/7/2013

NEW YORK, June 7,­­­­ 2013 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (OTCQB: ATNM) announced today the recent issuance of 2,095,204 of its shares of common stock pursuant to the exercise of A-Warrants originally issued in connection with a private placement that closed in January 2013.  The warrants were exercised at US$ 1.65 per share, resulting in gross proceeds of US$ 3,457,087 for the Company.  As of June 7, 2013 the total number of outstanding common stock is 15,825,394 shares.

"The proceeds from these exercised warrants will be used for the Companies clinical and preclinical programs and for general working capital," said Sergio Traversa, Interim Chief Executive Officer of Actinium Pharmaceuticals.  "This capital will allow us to continue to develop our drug candidates for treatment of the most difficult forms of cancer, including Acute Myeloid Leukemia, where they have made significant advances and already helped a number of patients," added Dragan Cicic, MD, Chief Medical Officer of Actinium Pharmaceuticals.  "The Company intends to advance its programs into late phases of clinical trials and add new programs by the end of 2013."

Shareholders exercised 2,095,204 (67.2%) of the 3,118,988 originally issued A-warrants. 

About Actinium Pharmaceuticals

Actinium Pharmaceuticals, Inc., based in New York, NY, is a biopharmaceutical company that develops innovative alpha particle immunotherapeutics based on its proprietary platform for the therapeutic utilization of alpha particle emitting actinium-225 and bismuth-213 radiopharmaceuticals in association with monoclonal antibodies.

For more information:

Visit our web site www.actiniumpharmaceuticals.com or

Contact:
'/>"/>

SOURCE Actinium Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
2. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
3. Cactus Ventures, Inc. Changes Name to Actinium Pharmaceuticals, Inc.
4. Actinium Pharmaceuticals, Inc. To Present at the 15th Annual BIO CEO Investor Conference
5. Actinium Pharmaceuticals to Present at EMIT Targeted Radiotherapy Conference
6. University of Pennsylvania joins Actinium Pharmaceuticals Multicenter Actimab-A Trial
7. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
8. Actinium Pharmaceuticals Sponsors Webinar on Clinical Use of Alpha Immunotherapy
9. Actinium Pharmaceuticals Announces New Round of Financing
10. Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
11. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... 2014  UBM Medica US announces that Endocrinology ... other clinicians who treat patients with type 2 ... use of insulin .  Nearly all ... therapy – daily injections of one or more ... the function of pancreatic beta cells. Insulin is a ...
(Date:10/17/2014)... -- Ameritox SM , the nation,s leader in medication monitoring ... , M.D., as Chief Medical Officer. In this role, ... for healthcare providers, patients and managed care plans.   ... variety of healthcare companies that have provided him with ... health sides of Ameritox,s business. He most recently served ...
(Date:10/17/2014)... Oct. 17, 2014   ndd Medical Technologies , ... employing precise ultrasound technology, announced that its EasyOne Pro® ... Healthcare Center , a 140,000 square foot, 44-bed hospital ... hospital serves a large number of Native ... Oklahoma and beyond. A portion of its ...
Breaking Medicine Technology:Endocrinology Network Features Special Coverage on Effective Use of Insulin 2Endocrinology Network Features Special Coverage on Effective Use of Insulin 3Ameritox Appoints New Chief Medical Officer 2EasyOne Pro Mobile Respiratory Testing from ndd Medical Technologies Chosen by Choctaw Nation 2
... Inc. (Nasdaq: IDIX ), a biopharmaceutical company ... the treatment of human viral,and other infectious diseases, ... ended March 31, 2008. At March 31, 2008, ... million., 2008 Year-to-Date Business Highlights ...
... The current industrial,farm animal production (IFAP) system ... and the welfare of the animals themselves,according to ... Pew,Commission on Industrial Farm Animal Production (PCIFAP), in ... the negative effects of the IFAP,system are too ...
Cached Medicine Technology:Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results 2Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results 3Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results 4Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results 5Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results 6Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results 7Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment 2Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment 3Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment 4Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment 5Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment 6Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment 7
(Date:10/20/2014)... WA (PRWEB) October 20, 2014 My ... workflow management software application. The new module enables ... patients receive full life-cycle quality care. , This application ... others within their practice, attach a to-do item to ... fit, and even set up reoccurring reminders for follow-ups. ...
(Date:10/20/2014)... 2014 Myoderm announced ... Director of their CentralSource service. Matthew ... innovative turnkey drug sourcing, distribution, and management service ... 12 years of industry experience, in both business ... peak of their international success to help clients ...
(Date:10/20/2014)... October 20, 2014 Based on ... the only imaging assays capable of determining DNA ... test.  With these three dimensions of high-resolution data, ... detect the widest range of disease-causing genetic rearrangements, ... by other genomic tools, including today’s advanced sequencing ...
(Date:10/20/2014)... 20, 2014 Unveiled at the Sept. 18 ... Scorecard conservatively estimates member hospital ROI on membership dues at ... The Center provides $12.50 in value to member hospitals. The ... – Member Dues)/Member Dues. , “This is the first ... and we think the methodology is really sound,” said ...
(Date:10/20/2014)... Texas (PRWEB) October 20, 2014 Houston ... to present the key elements of his innovative ... professor to plastic surgery residents and faculty at ... , where he, too, was once a medical student. ... the largest private cosmetic plastic surgery practices in Texas, ...
Breaking Medicine News(10 mins):Health News:My Clients Plus Announces New Workflow Management Software 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
... disorder (ADHD), a state of serious impairments in both ... labels for one of the most prevalent conditions in ... persists into adulthood. ADHD is conservatively estimated to occur ... but more permissive criteria yield estimates of up to ...
... children attend a counseling session before undergoing genetic testing for ... to be up front with their kids about the tests ... study released today here at the annual meeting of the ... found that when the co-parenta spouse, partner or other adult ...
... link between the breathing disorder, arterial trouble , FRIDAY, ... deliver continuous positive airway pressure (CPAP) to treat people ... atherosclerosis -- hardening of the arteries -- within months, ... the first evidence of a direct link between obstructive ...
... Garcia, Huffman), the California Routine HIV Screening,Bill, ... Foundation, the,California Medical Association, & the Health ... & Reduce HIV Transmission, SACRAMENTO, Calif., ... operator of the largest non-government HIV testing,program ...
... Idaho, Oct. 12 NightHawk,Radiology Holdings, Inc. (Nasdaq: ... groups across the United States, today announced that,it will ... at 8:30 a.m.,(ET) with management to review the company,s ... The third quarter conference call will be held ...
... Fred Hutchinson Cancer Research Center in January, SEATTLE, Oct. ... representatives has released a list of 10 players, one,of whom ... January.,The 2007 Hutch Award finalists are: -- Paul Byrd, ... Orlando Hudson, Arizona Diamondbacks -- Raul Ibanez, Seattle Mariners ...
Cached Medicine News:Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 2Health News:Computerized training of working memory is a promising therapeutic strategy in ADHD 3Health News:Couples attending counseling sessions together better prepared to ease children's concerns 2Health News:Sleep Apnea Treatment Helps Stave Off Heart Disease 2Health News:Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF 2Health News:Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF 3Health News:Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF 4Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2Health News:Ten Finalists Chosen for 2007 Hutch Award 2